TC-G-1008;化合物TC-G-1008GPR39-C3;GPR39-C3 (2024/9/8)
簡介:tc-g-1008 (gpr39-c3) is a gpr39 (zinc receptor) agonist (ec50 values are 0.4 and 0.8 nm for rat and human receptors respectively).
M2I-1;化合物M2I-1M2I 1;M2I 1 (2024/9/8)
簡介:m2i-1 a small mad2 inhibitor-1. the first small molecule inhibitor targeting the binding of mad2 to cdc20, an essential proteinprotein interaction (ppi) within the sac. it can disturbs conformational dynamics of mad2 critical for complex formation with cdc20. it can also inhibited the mad2-f-mbp1 interaction in fp assays.
TA-02;化合物TA-02TA-02 (2024/9/8)
簡介:ta-02 is a p38 mapk inhibitor with ic50 of 20 nm.ta-02 especially inhibits tgfbr-2.
TA-01;化合物TA-01TA-01 (2024/9/8)
簡介:ta-01 is a potent ck1 and p38 mapk inhibitor, with ic50s of 6.4 nm, 6.8 nm, 6.7 nm for ck1ε, ck1δ and p38 mapk, respectively.
Tapinarof;苯烯莫德GSK2894512|||Benvitimod|||WBI 1001;GSK2894512|||Benvitimod|||苯烯莫德|||WBI 1001 (2024/9/8)
簡介:tapinarof (benvitimod) is targeted as a topical cream treatment for psoriasis, a chronic autoimmune skin disease.
TFAP;化合物TFAPN-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide;N-(5-Aminopyridin-2-yl)-4-(trifluor (2024/9/8)
簡介:tfap (n-(5-aminopyridin-2-yl)-4-(trifluoromethyl)benzamide) is a selective cyclooxygenase-1 (cox-1) inhibitor
Tenovin-2;化合物Tenovin-2Tenovin-2 (2024/9/8)
簡介:tenovin-2 has a wide range of applications in life science related research.
Branaplam;化合物L(fēng)MI 070LMI 070|||NVS-SM1;LMI 070|||NVS-SM1 (2024/9/8)
簡介:branaplam (lmi 070) is a highly potent, selective and orally active small molecule smn2 splicing modulator.
Parimifasor;化合物ParimifasorLYC30937;LYC30937 (2024/9/8)
簡介:parimifasor (lyc30937) is an immunomodulator, with anti-inflammatory activity.
Azemiglitazone;化合物MSDC 0602MSDC 0602;MSDC 0602 (2024/9/8)
簡介:azemiglitazone (msdc 0602) is an insulin sensitizer potentially for the treatment of diabetes.
E260;化合物Fer and FerT inhibitorFer and FerT inhibitor;Fer and FerT inhibitor (2024/9/8)
簡介:e260 (fer and fert inhibitor) is a fer/fert kinase inhibitor
R-7050;化合物R-7050TNF-α Antagonist III;TNF-α Antagonist III (2024/9/8)
簡介:r-7050 (tnf-α antagonist iii), a tumor necrosis factor receptor (tnfr) antagonist, exhibits heightened selectivity for tnfα.
Protein kinase inhibitors 1;化合物Protein kinase inhibitors 1Protein kinase inhibitors 1 (2024/9/8)
簡介:protein kinase inhibitors 1 is a novel inhibitor of hipk2 with an ic50 of 74 nm and kd of 9.5 nm.
Ralinepag;化合物RalinepagAPD811;APD811 (2024/9/8)
簡介:ralinepag (apd811) is a potent, orally bioavailable agonist of non-prostanoid prostacyclin (ip) receptor, with ec50s of 8.5 nm, 530 nm and 850 nm for human and rat ip receptor and human dp1 receptor, respectively.
GNE-6776;化合物GEN6776GEN6776;GEN6776 (2024/9/8)
簡介:gne-6776 is a selective usp7 inhibitor.
Asimadoline阿西馬朵林EMD-61753|||阿西馬朵林 (2024/9/8)
簡介:asimadoline (emd-61753) is a proprietary small molecule therapeutic, originally discovered by merck kgaa of darmstadt, germany. asimadoline was originally developed to treat peripheral pain such as arthritis. asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. it has shown encouraging clinical efficacy for the treatment of ibs in a barostat study in ibs patients and has the potential for treating other gastrointestinal diseases.
NSC 6038;4-氯-N,N-二-N-丙基苯甲酰胺4-chloro-N,N-dipropylbenzamide|||4-Chloro-N,N-di-n-propylbenzaMide;4-chlo (2024/9/8)
簡介:nsc-6038 (4-chloro-n,n-dipropylbenzamide) is a benzamide-based bioactive compound with a wide range of biological activities and has been shown to possess anti-inflammatory, antioxidant and anti-angiogenic activities, and has also been shown to be effective in the treatment of a wide range of diseases such as cancer, diabetes and cardiovascular diseases.
NSC 4810;化合物NSC 4810NSC 4810 (2024/9/8)
簡介:nsc 4810 is an amide bioactive compound that has been used as a substrate for cytochrome p450 enzymes in vivo and as a substrate for acetylcholinesterase in vitro.
NSC 404988;4-氯-N,N-二乙基苯甲酰胺NSC 404988 (2024/9/8)
簡介:nsc 404988 is a benzamide-based bioactive compound used in the synthesis of compounds and the preparation of drugs, and has also been used in the study of drug metabolism and the analysis of metabolites in biological systems.
Seladelpar;化合物MBX 8025MBX 8025;MBX 8025 (2024/9/8)
簡介:seladelpar (mbx 8025) has been used in trials studying the treatment of hyperlipidemia.
SPI--112Me;化合物SPI--112MeSPI--112Me (2024/9/8)
簡介:spi--112me, a prodrug of spi-112, preferentially inhibits the ptpase activity of shp2 over shp1 and ptp1b by more than 20-fold in cell-free assays.
TC-O 9311;TC-O 9311TCO-9311|||TC-O9311|||TCO 9311|||TC-O 9311|||TCO9311|||TC-O-9311;TCO-9311|||TC-O9 (2024/9/8)
簡介:tc-o 9311 (tco-9311) is an effective agonist of gpr139 (ec50 = 39 nm in cho-k1 cells expressing human gpr139).
TC-O 9311 free base;化合物TC-O 9311TC-O 9311 free base (2024/9/8)
簡介:tc-o 9311 is a potent gpr139 agonist.
PGD2-IN-1;化合物PGD2-inhibitorPGD2-inhibitor;PGD2-inhibitor (2024/9/8)
簡介:pgd2-in-1 (pgd2-inhibitor) is an effective dp receptor antagonist (ic50:0.3 nm), a compound that can inhibit prostaglandin d2 (pgd2) signaling. pgd2-in-1 specifically targets and regulates the activity of pgd2 receptors or enzymes involved in pgd2 synthesis or metabolism.
Siramesine;西拉美新Lu 28-179;西拉美新|||Lu 28-179 (2024/9/8)
簡介:siramesine (lu 28-179)(lu 28-179) is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.lysosome-destabilizing agent siramesine can induce rapid cell death in a number of cell lines at concentrations above 20 μm. in hacat cells, cell death was accompanied by caspase activation, rapid loss of mitochondrial membrane potential (mmp), cytochrome c release, cardiolipin peroxidation and typical apoptotic
ML-098;化合物ML-098CID-7345532;CID-7345532 (2024/9/8)
簡介:ml-098 (cid-7345532) is an activator of the gtp-binding protein rab7 (ec50: 77.6 nm).
BGG463;化合物K 0859K 0859;K 0859 (2024/9/8)
簡介:bgg463 (k 0859) can inhibit c-abl-t334i, bcr-abl and bcr-abl-t315i variants with a 50% inhibitory concentration (ic50) of 0.25 μm, 0.09 μm and 0.590 μm, respectively.
3,8-Dihydroxy-2,4,6-trimethoxyxanthone;化合物 T46173,8-Dihydroxy-2,4,6-trimethoxyxanthone (2024/9/8)
簡介:3,8-dihydroxy-2,4,6-trimethoxyxanthone is a natural product of cystopteris, athyriaceae. the catalog number is t4617 and the cas number is 65008-17-5. 3,8-dihydroxy-2,4,6-trimethoxyxanthone can be used as a reference standard.
簡介:metoclopramide (5-chloro-2-methoxyprocainamide) is a dopamine d2 antagonist which has been used for treatment of a variety of gastrointestinal symptoms over the last thirty years. in various countries, metoclopramide is the antiemetic drug of choice in pregnant women. findings provide reassurance regarding the safety of metoclopramide for the fetus when the drug is given to women to relieve nausea and vomiting during pregnancy. evidence also supports its use for gastroparesis (poor stomach empty
Balsalazide sodium hydrate;巴柳氮鈉水合物Balsalazide disodium dihydrate|||Balsalazide disodium salt dihydra (2024/9/8)
簡介:balsalazide sodium hydrate (balsalazide disodium) is an anti-inflammatory compound used in the treatment of inflammatory bowel disease.balsalazide sodium hydrate is a new 5-aminosalicylic acid (5-asa) containing prodrug. high dose balsalazide sodium hydrate(3.0 g twice daily) was superior in maintaining remission in patients with ulcerative colitis compared with a low dose (1.5 g twice daily) or a standard dose of mesalazine (0.5 g three times daily). all three treatments were safe and well tole